After we had confirmed that patients with brain cancer can mount a measurable cellular immune responses to the mesothelin precursor, we wanted to map which epitopes within the mesothelin protein would evoke the strongest IFN-γ response by T cells. This evidence concerns the gene MSLN and brain cancer.